GENEVA, July 27 -- BRANDARIS THERAPEUTICS B.V. filed a patent application (IB2025/000617) for “5,6-BICYCLIC 5-HT2AR AGONISTS AND USES THEREOF”. With publication no. WO/2026/078446, here are the other details related to the patent application:
Kind: Later publication of international search report [A3]
IPC: A61P 25/26
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....